Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Lobular”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Testing effectiveness (Phase 2)Study completedNCT01869764
What this trial is testing

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast Cancer+6 more
Wake Forest University Health Sciences 57
Testing effectiveness (Phase 2)UnknownNCT01641406
What this trial is testing

"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"

Who this might be right for
Infiltrating Duct and Lobular Carcinoma In SituInvasive Lobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00416403
What this trial is testing

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 35
Testing effectiveness (Phase 2)Looking for participantsNCT06184750
What this trial is testing

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+3 more
National Cancer Institute (NCI) 200
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Not applicableEnded earlyNCT00556907
What this trial is testing

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

Who this might be right for
Breast Cancer
University of Southern California 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009044
What this trial is testing

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Who this might be right for
Cancer SurvivorDuctal Breast Carcinoma In SituInvasive Breast Carcinoma
Northwestern University 156
Testing effectiveness (Phase 2)Looking for participantsNCT07309770
What this trial is testing

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Who this might be right for
Urachal CancerAdvanced Solid Tumor CancerAntibody-drug Conjugates
Sheng Zhang 90
Testing effectiveness (Phase 2)Looking for participantsNCT05982496
What this trial is testing

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

Who this might be right for
Breast Cancer FemaleLobular Breast CarcinomaPET/MRI+2 more
Università Vita-Salute San Raffaele 119
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Looking for participantsNCT06218303
What this trial is testing

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma in Situ
Finn, Olivera, PhD 50
Large-scale testing (Phase 3)Study completedNCT00004205
What this trial is testing

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 8,028
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Next Page